Strengthening Compliance Based on High Ethical Standards
First written in FY2016. 2 of 6 entries say "Restated". Latest entry: 2026-05-21.
22 other companies' latest entry also says "Advanced".
- 2026-05-21AdvancedGeneral Meetings of Shareholders
「The Group Compliance Committee met four times a year in the presence of Audit & Supervisory Board members to identify compliance issues and consider responses.」
The operating status of the compliance framework was disclosed in detail, including the committee's meeting frequency, third-party assessments, employee awareness surveys and internal and external reporting channels available for anonymous use. - FY2025AdvancedAnnual report
「Under the ONO Group Code of Conduct, we have established the Global Compliance Policy and other policies, and have built a compliance management structure that includes the Group Compliance Committee and internal and external hotlines for reporting compliance violations.」
The compliance structure has been maintained and made more specific as a system that includes a group committee, internal and external reporting hotlines, global policies, and regular risk identification and monitoring. - FY2023ReframedAnnual report
「Under the ONO Group Code of Conduct, we have established the Global Compliance Policy and other policies, and have built a compliance structure that includes a Compliance Committee and internal and external hotlines for reporting compliance violations and seeking workplace advice.」
The compliance policy based on high ethical standards has been made specific through a structure including global policies, a committee, and internal and external reporting and consultation channels. - FY2018RestatedAnnual report
「We are deeply aware of our responsibility as a pharmaceutical company handling products that affect human life, and are working to further strengthen compliance and to act based not only on compliance with laws and regulations but also on high ethical standards.」
Our responsibilities as a pharmaceutical company, high ethical standards and stronger compliance have been reaffirmed as basic policies. - FY2017RestatedAnnual report
「Deeply aware of our responsibility as a pharmaceutical company handling products that affect human life, we are working to further strengthen compliance and to act based not only on compliance with laws and regulations but also on high ethical standards.」
Our responsibilities as a pharmaceutical company, high ethical standards and stronger compliance have been reaffirmed as basic policies. - FY2016First statedAnnual report
「Deeply aware of our responsibility as a pharmaceutical company handling products that affect human life, we are working to further strengthen compliance and to act based not only on compliance with laws and regulations but also on high ethical standards.」
Based on our responsibilities as a pharmaceutical company, compliance with laws and regulations and conduct grounded in high ethical standards are our basic principles.